Frontiers | Inhibition of Heat Shock Protein 90 by 17-AAG Reduces Inflammation via P2X7 Receptor/NLRP3 Inflammasome Pathway and Increases Neurogenesis After Subarachnoid Hemorrhage in Mice | Molecular Neuroscience
Pharmaceuticals | Free Full-Text | Heat Shock Protein 90 and Role of Its Chemical Inhibitors in Treatment of Hematologic Malignancies | HTML
Combining an Hsp70 inhibitor with either an N- or C-terminal Hsp90 inhibitor produces mechanistically distinct phenotypes - Organic & Biomolecular Chemistry (RSC Publishing) DOI:10.1039/C5OB00147A
Hsp90 (Heat Shock Protein 90) Inhibitor Occupancy Is a Direct Determinant of Client Protein Degradation and Tumor Growth Arrest in Vivo* - Journal of Biological Chemistry
Molecular Stress-inducing Compounds Increase Osteoclast Formation in a Heat Shock Factor 1 Protein-dependent Manner* - Journal of Biological Chemistry
17-AAG - BML-EI308 - Enzo Life Sciences
Action mechanism of 17-DMAG as an HSP90 inhibitor (canonical pathway).... | Download Scientific Diagram
Targeting Hsp90 by 17-AAG in leukemia cells: mechanisms for synergistic and antagonistic drug combinations with arsenic trioxide and Ara-C | Leukemia
17‑AAG synergizes with Belinostat to exhibit a negative effect on the proliferation and invasion of MDA‑MB‑231 breast cancer cells
Vorinostat in solid and hematologic malignancies | Journal of Hematology & Oncology | Full Text
Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin inhibits the proliferation of ARPE-19 cells | Journal of Biomedical Science | Full Text
Frontiers | Inhibition of Heat Shock Protein 90 by 17-AAG Reduces Inflammation via P2X7 Receptor/NLRP3 Inflammasome Pathway and Increases Neurogenesis After Subarachnoid Hemorrhage in Mice | Molecular Neuroscience
Hsp90 inhibitor - Wikipedia
The HSP90 Inhibitor, 17-AAG, Influences the Activation and Proliferati | DDDT
17-AAG inhibits vemurafenib-associated MAP kinase activation and is synergistic with cellular immunotherapy in a murine melanoma model